Reforming Paediatric Drug Regulations in Canada: A Clinical and an Access Imperative

Area of Science:

• Pediatric Pharmacology
• Drug Safety Regulations
• Health Policy

Background:

• Children require the same drug safety, efficacy, and access standards as adults.
• Canada's current regulations fall short compared to international standards for pediatric medications.
• Lack of specific regulations leads to many drugs being used off-label for Canadian children.

Purpose of the Study:

• To highlight the need for enhanced paediatric regulations in Canada.
• To address the disparity in access to paediatric medications compared to international benchmarks.
• To underscore the implications of absent paediatric indications on drug safety and formulary access.

Main Methods:

• Analysis of existing Canadian drug regulations concerning paediatric use.
• Comparison of Canadian paediatric drug policies with leading international regulatory bodies.
• Review of the consequences of off-label medication use in pediatric populations.

Main Results:

• Canada's regulatory framework for paediatric medications is not aligned with international best practices.
• Many drugs approved for children in other countries are not officially indicated for paediatric use in Canada.
• The absence of paediatric indications creates significant challenges for drug safety, health technology assessments, and formulary inclusion.

Conclusions:

• Urgent implementation of paediatric regulations is necessary in Canada.
• Updated regulations will improve medication safety, efficacy, and access for children.
• Aligning with international standards is crucial for evidence-based paediatric healthcare in Canada.